MPCI Stock Overview
Memphis Pharmaceuticals & Chemical Industries produces and sells pharmaceutical products for human and veterinary use in Egypt.
Memphis Pharmaceuticals & Chemical Industries Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||ج.م16.42|
|52 Week High||ج.م22.50|
|52 Week Low||ج.م12.20|
|1 Month Change||9.03%|
|3 Month Change||-0.12%|
|1 Year Change||-13.67%|
|3 Year Change||69.80%|
|5 Year Change||-7.65%|
|Change since IPO||-45.67%|
Recent News & Updates
|MPCI||EG Pharmaceuticals||EG Market|
Return vs Industry: MPCI underperformed the EG Pharmaceuticals industry which returned 6.5% over the past year.
Return vs Market: MPCI underperformed the EG Market which returned 9.9% over the past year.
|MPCI Average Weekly Movement||6.1%|
|Pharmaceuticals Industry Average Movement||4.9%|
|Market Average Movement||5.7%|
|10% most volatile stocks in EG Market||8.9%|
|10% least volatile stocks in EG Market||3.5%|
Stable Share Price: MPCI is not significantly more volatile than the rest of EG stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: MPCI's weekly volatility (6%) has been stable over the past year.
About the Company
Memphis Pharmaceuticals & Chemical Industries produces and sells pharmaceutical products for human and veterinary use in Egypt. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal health products in powder form, as well as in oral and injectable solution forms.
Memphis Pharmaceuticals & Chemical Industries Fundamentals Summary
|MPCI fundamental statistics|
Is MPCI overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|MPCI income statement (TTM)|
|Cost of Revenue||ج.م401.87m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||13.17|
|Net Profit Margin||13.44%|
How did MPCI perform over the long term?See historical performance and comparison